Breaking Boundaries in Process Development

The field of cell and gene therapy has enjoyed spectacular growth in recent years and is destined to be one of the strongest growing markets in the biopharmaceutical industry. More than 20 approved gene therapies are already on the market, providing potentially life-saving treatment options for patients with rare diseases. Manufacturing these novel therapies requires a continual supply of billions of cells, generated by robust, scalable, and economically viable bioprocesses.

In this webinar, experts from industry and academia will share their insights and experiences as they lay out the potential of stirred-tank bioreactors for cell and gene therapy development and manufacturing.

Key Learning Objectives:

• Advances in commercializing cell and gene therapy development
• The key role of stirred-tank bioreactors from research to manufacturing
• How to bring life-saving cell and gene therapies to market